Company Filing History:
1 out of 1,743 
1 out of 11 
1 out of 31 
Years Active: 2022
Title: The Innovations of Said Kamel
Introduction
Said Kamel is a notable inventor based in Amiens, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular conditions. His work focuses on innovative approaches to address cardiovascular calcification, a critical health issue.
Latest Patents
Said Kamel holds a patent for "Pharmaceutical compositions for use in the treatment of cardiovascular calcification." This invention demonstrates that the phosphatase and hydrolase domains of soluble epoxide hydrolase (sEH) regulate the cardiovascular calcification process. The research reveals that inhibiting the phosphatase domain of sEH could serve as a new pharmacological target for preventing cardiovascular calcification. The patent outlines a therapeutically effective amount of an inhibitor of phosphatase activity of sEH for treating cardiovascular calcification in individuals in need.
Career Highlights
Throughout his career, Said Kamel has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université de Rouen Normandie. His research has contributed to advancements in medical science, particularly in understanding and treating cardiovascular diseases.
Collaborations
Said Kamel has collaborated with notable colleagues, including Jeremy Bellien and Isabelle Six. These partnerships have enhanced his research and contributed to the development of innovative solutions in the pharmaceutical field.
Conclusion
Said Kamel's work exemplifies the impact of innovation in medicine, particularly in addressing cardiovascular health challenges. His patent and collaborations highlight the importance of research in developing effective treatments.